These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801. Zajaczkowski W; Czyrak A; Wedzony K Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466 [TBL] [Abstract][Full Text] [Related]
4. The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801. Bubeníková-Valesová V; Votava M; Pálenícek T; Horácek J Neuropharmacology; 2007 Mar; 52(4):1071-8. PubMed ID: 17196227 [TBL] [Abstract][Full Text] [Related]
5. The 5-HT2C receptor antagonist RO 60-0491 counteracts rats' retention deficits in a recognition memory task. Pitsikas N; Sakellaridis N Brain Res; 2005 Aug; 1054(2):200-2. PubMed ID: 16040008 [TBL] [Abstract][Full Text] [Related]
6. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Karasawa J; Hashimoto K; Chaki S Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919 [TBL] [Abstract][Full Text] [Related]
7. Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. de Lima MN; Laranja DC; Bromberg E; Roesler R; Schröder N Behav Brain Res; 2005 Jan; 156(1):139-43. PubMed ID: 15474658 [TBL] [Abstract][Full Text] [Related]
8. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice. Scorza MC; Castañé A; Bortolozzi A; Artigas F Neuropharmacology; 2010; 59(1-2):112-20. PubMed ID: 20412811 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice. Nilsson M; Hansson S; Carlsson A; Carlsson ML Neuroscience; 2007 Oct; 149(1):123-30. PubMed ID: 17826918 [TBL] [Abstract][Full Text] [Related]
10. Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801. Cunha GM; Canas PM; Melo CS; Hockemeyer J; Müller CE; Oliveira CR; Cunha RA Exp Neurol; 2008 Apr; 210(2):776-81. PubMed ID: 18191838 [TBL] [Abstract][Full Text] [Related]
11. Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory. Pitsikas N; Boultadakis A; Sakellaridis N Neuroscience; 2008 Jun; 154(2):454-60. PubMed ID: 18472348 [TBL] [Abstract][Full Text] [Related]
12. Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats. Kusljic S; Brosda J; Norman TR; van den Buuse M Brain Res; 2005 Jul; 1049(2):217-26. PubMed ID: 15953591 [TBL] [Abstract][Full Text] [Related]
13. Memantine and recognition memory: possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine. Pitsikas N; Sakellaridis N Eur J Pharmacol; 2007 Oct; 571(2-3):174-9. PubMed ID: 17628527 [TBL] [Abstract][Full Text] [Related]
14. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors. Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909 [TBL] [Abstract][Full Text] [Related]
15. NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia. Matsuoka T; Sumiyoshi T; Tanaka K; Tsunoda M; Uehara T; Itoh H; Kurachi M Brain Res; 2005 Aug; 1053(1-2):131-6. PubMed ID: 16051205 [TBL] [Abstract][Full Text] [Related]
16. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission. Eriksson TM; Madjid N; Elvander-Tottie E; Stiedl O; Svenningsson P; Ogren SO Neuropharmacology; 2008 Jun; 54(7):1041-50. PubMed ID: 18394658 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801. Seillier A; Giuffrida A Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985 [TBL] [Abstract][Full Text] [Related]
18. Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice. Kos T; Popik P; Pietraszek M; Schäfer D; Danysz W; Dravolina O; Blokhina E; Galankin T; Bespalov AY Eur Neuropsychopharmacol; 2006 May; 16(4):297-310. PubMed ID: 16288851 [TBL] [Abstract][Full Text] [Related]
19. The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents. van der Staay FJ; Rutten K; Bärfacker L; Devry J; Erb C; Heckroth H; Karthaus D; Tersteegen A; van Kampen M; Blokland A; Prickaerts J; Reymann KG; Schröder UH; Hendrix M Neuropharmacology; 2008 Oct; 55(5):908-18. PubMed ID: 18674549 [TBL] [Abstract][Full Text] [Related]
20. [Effects of NMDA and metabotropic glutamate receptors antagonists in working memory task in rats]. Novitskaia IuA; Dravolina OA; Zvartau EE; Danysz W; Bespalov AIu Zh Vyssh Nerv Deiat Im I P Pavlova; 2009; 59(4):446-52. PubMed ID: 19795807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]